- Home
- YOTA vs CODX Comparison
YOTA vs CODX Comparison
Compare YOTA & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOTA
- CODX
- Stock Information
- Founded
- YOTA 2021
- CODX 2013
- Country
- YOTA United States
- CODX United States
- Employees
- YOTA N/A
- CODX N/A
- Industry
- YOTA Farming/Seeds/Milling
- CODX Medical/Dental Instruments
- Sector
- YOTA Consumer Staples
- CODX Health Care
- Exchange
- YOTA Nasdaq
- CODX Nasdaq
- Market Cap
- YOTA 43.9M
- CODX 39.3M
- IPO Year
- YOTA 2022
- CODX 2017
- Fundamental
- Price
- YOTA $11.25
- CODX $1.06
- Analyst Decision
- YOTA
- CODX Hold
- Analyst Count
- YOTA 0
- CODX 1
- Target Price
- YOTA N/A
- CODX $1.50
- AVG Volume (30 Days)
- YOTA 1.3K
- CODX 90.9K
- Earning Date
- YOTA 01-01-0001
- CODX 11-07-2024
- Dividend Yield
- YOTA N/A
- CODX N/A
- EPS Growth
- YOTA 35.55
- CODX N/A
- EPS
- YOTA 0.13
- CODX N/A
- Revenue
- YOTA N/A
- CODX $7,321,012.00
- Revenue This Year
- YOTA N/A
- CODX N/A
- Revenue Next Year
- YOTA N/A
- CODX N/A
- P/E Ratio
- YOTA $85.06
- CODX N/A
- Revenue Growth
- YOTA N/A
- CODX 57.16
- 52 Week Low
- YOTA $10.35
- CODX $1.00
- 52 Week High
- YOTA $15.49
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- YOTA 72.10
- CODX 34.55
- Support Level
- YOTA $11.17
- CODX $1.02
- Resistance Level
- YOTA $11.23
- CODX $1.09
- Average True Range (ATR)
- YOTA 0.03
- CODX 0.05
- MACD
- YOTA 0.01
- CODX -0.01
- Stochastic Oscillator
- YOTA 100.00
- CODX 21.74
About YOTA Yotta Acquisition Corporation
Yotta Acquisition Corp is a shell company.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.